We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
10 Year Est. Return
AUM
$4.38B
AUM Growth
+$659M
Cap. Flow
+$520M
Cap. Flow %
11.86%
Top 10 Hldgs %
40.13%
Holding
803
New
165
Increased
174
Reduced
202
Closed
188

Top Buys

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$217M
2
INTU icon
Intuit
INTU
+$172M
3
BKNG icon
Booking.com
BKNG
+$94.4M
4
LIN icon
Linde
LIN
+$91.3M
5
HD icon
Home Depot
HD
+$74.1M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$161M
2
AVGO icon
Broadcom
AVGO
+$99.6M
3
COST icon
Costco
COST
+$51.8M
4
NFLX icon
Netflix
NFLX
+$50.8M
5
ETN icon
Eaton
ETN
+$39.4M

Sector Composition

Rank Sector Weight
1 Technology 32.45%
2 Healthcare 14.8%
3 Consumer Discretionary 10.18%
4 Financials 8.84%
5 Communication Services 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HFRO
551
Highland Opportunities and Income Fund
HFRO
$400M
$62K ﹤0.01%
+10,113
New +$61.6K
SVC
552
Service Properties Trust
SVC
$1.1B
$59.3K ﹤0.01%
+2,600
New +$64.7K
GEVO icon
553
Gevo
GEVO
$445M
$57.2K ﹤0.01%
35,113
+1,113
+3% +$902
AVXL icon
554
Anavex Life Sciences
AVXL
$230M
$56.8K ﹤0.01%
+10,000
New +$57.7K
AUTL
555
Autolus Therapeutics
AUTL
$405M
$56.3K ﹤0.01%
15,500
+3,000
+24% +$12K
ORLA
556
Orla Mining
ORLA
$3.48B
$56K ﹤0.01%
+13,995
New +$55.4K
LEV
557
DELISTED
The Lion Electric Company
LEV
$54.7K ﹤0.01%
80,600
+56,200
+230% +$42.4K
PDSB icon
558
PDS Biotechnology
PDSB
$39.2M
$53.5K ﹤0.01%
14,000
IOBT
559
DELISTED
IO Biotech
IOBT
$47.3K ﹤0.01%
45,000
INVZ icon
560
Innoviz Technologies
INVZ
$138M
$46.2K ﹤0.01%
55,767
-4,233
-7% -$3.22K
USGOW
561
DELISTED
U.S. GoldMining Inc Warrant
USGOW
$45.5K ﹤0.01%
64,128
-1
-0% -$1
OMGA
562
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$44K ﹤0.01%
36,080
AMTX icon
563
Aemetis
AMTX
$130M
$43.2K ﹤0.01%
18,800
-10,000
-35% -$28K
LLAP
564
DELISTED
Terran Orbital Corporation
LLAP
$40.9K ﹤0.01%
162,850
IAUX
565
i-80 Gold Corp
IAUX
$1.19B
$39.7K ﹤0.01%
34,200
+6,000
+21% +$6.29K
MIND icon
566
MIND Technology
MIND
$50M
$39.2K ﹤0.01%
+10,228
New +$42.9K
YCBD.PRA
567
DELISTED
cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
$37.6K ﹤0.01%
54,601
+15,337
+39% +$8.13K
INDO icon
568
Indonesia Energy Corp
INDO
$47.2M
$35.5K ﹤0.01%
15,000
-1,000
-6% -$2.81K
AZI
569
Autozi Internet Technology
AZI
$3.04M
$31.5K ﹤0.01%
+51
New +$39.6K
ORGN
570
DELISTED
Origin Materials
ORGN
$30.8K ﹤0.01%
667
SYRS
571
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$27.3K ﹤0.01%
+12,700
New +$45.6K
MHUA
572
DELISTED
Meihua International Medical Technologies
MHUA
$25.5K ﹤0.01%
250
+50
+25% +$4.58K
TSHA icon
573
Taysha Gene Therapies
TSHA
$1.68B
$25.1K ﹤0.01%
12,500
ZENV
574
DELISTED
Zenvia
ZENV
$25K ﹤0.01%
16,241
ME
575
DELISTED
23andMe Holding Co
ME
$17.4K ﹤0.01%
2,500

Similar funds

Marex Group's Q3 2024 Portfolio in Review

As of Q3 2024, Marex Group held 803 positions worth $4.38B, up 18% from $3.72B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Marex Group deployed $520M of net new capital in Q3 2024, opening 165 new positions and adding to 174 existing holdings. Its largest new stake was Linde: 200,101 shares worth $95.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $161M trimmed.

  • Marex Group's largest Q3 2024 buy was Linde: 200,101 shares worth $95.4M.
  • Marex Group added most to Strategy Inc in Q3 2024, an estimated $217M increase.
  • Marex Group's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $161M.
  • Marex Group fully exited Eaton in Q3 2024, selling an estimated $39.4M.
  • Marex Group's ten largest holdings make up 40% of its $4.38B portfolio in Q3 2024.
  • Marex Group opened 165 new positions and closed 188 in Q3 2024.
  • Marex Group's portfolio value rose 18% quarter-over-quarter to $4.38B.

Based on Marex Group's 13F filing for Q3 2024, filed 7 Apr 2026.